NCT02551198View on ClinicalTrials.gov

Comparison of Polyethylene Glycol With Ascorbic Acid and Oral Sulfate Solution for Bowel Preparation

PHASE3CompletedINTERVENTIONAL

Enrollment

184

Participants

Timeline

Start Date

November 1, 2015

Primary Completion Date

March 1, 2016

Study Completion Date

September 1, 2017

Conditions

Healthy

Interventions

DRUG

HAPREP®

"Arm1: HAPREP® (2L polyethylene glycol with ascorbic acid; PEG-Asc)~: : PEG-Asc(500mLx2 times q30min)\[PM 7-9, the day before colonoscopy\] + PEG-Asc(500mLx2 times q30min)\[AM 5-7, the day of colonoscopy\]"

DRUG

SUCLEAR®

Arm2: SUCLEAR® (oral sulfate solution; OSS): OSS(1b/177mL)\[PM 7-9, the day before colonoscopy\] + OSS(1b/177mL)\[AM 5-7, the day of colonoscopy\]

Trial Locations (1)

410-769

National Cancer Center, Goyang-si

All Listed Sponsors

collaborator

Daehang Hospital

OTHER

lead

National Cancer Center, Korea

OTHER_GOV

NCT02551198 - Comparison of Polyethylene Glycol With Ascorbic Acid and Oral Sulfate Solution for Bowel Preparation | Biotech Hunter | Biotech Hunter